Jean-Charles Soria: Cancer in 2026 – Key Facts for Oncologists
Jean-Charles Soria/gustaveroussy.fr

Jean-Charles Soria: Cancer in 2026 – Key Facts for Oncologists

Jean-Charles Soria, SVP and Oncology Therapeutic Area Head at Amgen, shared a post on X:

“Cancer in 2026 — key facts for oncologists

  • Burden: ~2.11M new cancer cases and ~626K deaths projected in the US (2026).
  • Mortality: Cancer death rates ↓34% since the early 1990s, averting ~4.8M deaths.
  • Survival: Overall 5-yr relative survival reached 70%(2015–2021), up from 49% in the mid-1970s.
  • Advanced disease: 5-yr survival for distant-stage cancers improved 17% → 35%, with major gains in lung, melanoma, and rectal cancer.
  • Unfinished work: Lung cancer remains the leading cause of cancer death.”

Title: Cancer statistics, 2026

Authors: Rebecca L. Siegel, Tyler B. Kratzer, Nikita Sandeep Wagle, Hyuna Sung, Ahmedin Jemal

Read the Full Article on CA: A Cancer Journal for Clinicians

Jean-Charles Soria: Cancer in 2026 - Key Facts for OncologistsMore posts featuring Jean-Charles Soria